LATEST BLOG

Market Recap. April 1-5, 2019

JT001

06-Apr-2019 10:05 AM

0

152

  The first week of Q2 trading saw SPY gain +2.16%, QQQ +2.78%, IWM +2.80%, IBB +2.80%. In case you missed this past week market movers news, here is the recap.

Monday the first trading day of Q2 2019, Dow Jones rallies +329.74 points, SPY +1.19%, QQQ +1.32%, IWM +1.09%, IBB +0.10%.

  • Advaxis Inc (ADXS- ADXS-PSA in Combination with KEYTRUDA prolonged survival in mCRPC. Stock up +10.15% to $6.51
  • Puma Biotechnology, Inc (PBYI) enter an exclusive license agreement to develop and commercialize Nerlynx with Pierre Fabre. Stock trading down -8.12% to $35.64 closed.
  • TG Therapeutics (TGTX)- reports positive interim data from UNITY-NHL Phase 2b. Stock trading as high as $9.30 before fades back to near flat close +0.62% to $8.09.
  • Lyft Inc (LYFT) selling down -11.85% to close at $69.01. Investors concern the grow and valuation of the company.

Tuesday Dow Jones end the three-day winning streak by closing red -79.29 points, SPY +0.05%, QQQ +0.38%, IWM -0.26%, IBB +0.81%.

  • Sangamo Therapeutics Inc (SGMO) clinical update of the early phase 1/2 Beta Thalassemia Gene-edited Cell Therapy
  • ADMA Biologics (ADMA)  announces FDA Approval of ASCENIV
  • Evok Pharma Inc (EVOK) EVOK receives CRL from the FDA for Gimoti NDA. Stock down -47%

Wednesday Dow Jones finished up +38.76 points, SPY +0.17%, QQQ +0.57%, IWM +0.52%, IBB +0.59%

  • Advanced Micro Devices Inc (AMD) Normura/Instinet starts at Buy, PT $33. Stock up +8.49% to $29.02
  • Iovance Biotherapeutics Inc (IOVA) to present new data from Ongoing studies of TUmor-Infiltrating Lympocyte (TIL) at ASCO from May 31 to June 4. Stock up 20.41%
  • Wynn Resorts Ltd (WYNN) with three straight up day and 5 day gain of 18.57%. Today's up 1.93% to $137.63

Thursday Dow Jones +166.50 points, SPY +0.27%, QQQ -0.04%, IWM +0.49%, IBB -0.41%

  • Recro Pharma (REPH) Recro to cut jobs seek a strategic partner for pain medication. Stock up 27.91% to $8.34
  • Tesla Inc (TSLA) disappointed investors after a reported decline of 31% in Q1 deliveries. Stock down -8.23% to $267.78
  • Tonix Pharm Hldg (TNXP)  plans to expand TNX-102 SL Phase 3 Program Beyond PTSD.  Stock up +20.60% to $2.81

Friday, March U.S. (NFP) nonfarm payrolls rise 196,00, Unemployment rate stays 3.8%

  • Arrowhead Research Corp (ARWR)- reported Mackay Shields LLC purchased in the 4Q of 33,000 shares, valued at $409,000
  • Corbus Pharma (CRBP) Buy at Jefferies, PT $18.00
  • Syros Pharmaceuticals (SYRS) announces pricing of $70 million concurrent public offerings.

Contact us:

Twitter: @BiotechMoney18

Email: TradersFish@gmail.com

Add Your Comment



Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.